KMDA.TA : Summary for KAMADA ORD ILS1.00 - Yahoo Finance

U.S. Markets closed

Kamada Ltd. (KMDA.TA)


Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Add to watchlist
2,205.00+4.00 (+0.18%)
At close: 10:24 AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2,201.00
Open2,201.00
Bid2,207.00 x 346500
Ask2,210.00 x 57900
Day's Range2,201.00 - 2,230.00
52 Week Range13.10 - 2,230.00
Volume33,915
Avg. Volume78,605
Market Cap803.04M
BetaN/A
PE Ratio (TTM)-19,864.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Kamada Ltd. breached its 50 day moving average in a Bearish Manner : KMDA-IL : November 23, 2016
    Capital Cube15 days ago

    Kamada Ltd. breached its 50 day moving average in a Bearish Manner : KMDA-IL : November 23, 2016

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Kamada Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • GlobeNewswire23 days ago

    Kamada Announces Collaboration Agreement with Yissum for Development of a Recombinant Human Alpha 1 Antitrypsin

    NESS ZIONA, Israel, Nov. 15, 2016-- Kamada Ltd. a plasma-derived protein therapeutics company focused on orphan indications, announced today that it has signed a collaboration agreement with Yissum Research ...

  • Associated Press28 days ago

    Kamada reports 3Q loss

    On a per-share basis, the Ness Ziona, Israel-based company said it had a loss of 3 cents. The biopharmaceutical posted revenue of $19.4 million in the period. Kamada expects full-year revenue in the range ...